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A series of new 1,3,4-oxadiazole derivatives, 4(a–h), containing 5-chloro-2-methoxy benzohydrazide moiety were synthesized by
the reaction of 5-chloro-2-methoxybenzoate with different aromatic carboxylic acids. These newly synthesized compounds were
characterized by FT-IR, 1HNMR,mass spectra, and also by elemental analysis. All the newly synthesized compoundswere screened
for their antibacterial and antifungal activities. Antimicrobial studies revealed that compounds 4c, 4f, and 4g showed significant
activity against tested strains.
1. Introduction
Resistance to number of antimicrobial agents among a variety
of clinically significant bacteria is becoming increasingly
important.There are various problems arising with the use of
antimicrobials such as local tissue irritation, interferencewith
wound healing process, hypersensitivity reactions, system
toxicity, narrow antimicrobial spectrum, and emergency
of resistance [1]. So, the increasing clinical importance of
drug resistant microbial pathogens has additional urgency
in microbiological and antifungal research. A wide variety
of heterocyclic systems have been explored for developing
pharmaceutically important molecules. Among them the
derivatives of oxadiazoles have been playing an important
role in the medicinal chemistry [2]. The 1,3,4-oxadiazole
derivatives have been found to exhibit diverse biological
activities such as antimicrobial [3, 4], anti HIV [5], antituber-
cular [6], antimalarial [7], anti-inflammatory [8, 9], anticon-
vulsant [10], and antitumor [11]. The 2,5-disubstituted-1,3,4-
oxadiazole derivatives are known for various pharmacologi-
cal activities such as antibacterial [12], antihypertensive [13],
anticonvulsant [14], and antiproliferative [15]. The choice of
1,3,4-oxadiazole is due to its multiapplicability in the field of
medicine. In the present study, some new 1,3,4-oxadiazoles
4(a–h) have been synthesized and characterized by different
spectral studies. All the new compounds were screened for
their antibacterial and antifungal studies.
2. Results and Discussion
2.1. Chemistry. The novel 1,3,4-oxadiazoles 4(a–h) were
synthesized according to Scheme 1. Formation of 1,3,4-
oxadiazole derivatives, 4(a–h), was confirmed by record-
ing their elemental analyses, FT-IR, 1H NMR, and mass
spectra. The absorptions around 3050 cm−1 in synthesized
compounds confirm the aromatic C–H stretching vibrations
and the appearance of a medium to strong absorption bands
above 1600 cm−1 due to a stretching vibration of the azome-
thine (C=N) bond formation in synthesized compound. The
1H NMR spectra of 4c showed that singlet in the region
of 𝛿, 3.99–3.90, is due to the three protons of the methoxy
groups.Themass spectra of 4c showedmolecular ion peak at









. The elemental analyses data showed good
agreement between the experimentally determined values
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and the theoretically calculated values within ±0.4%. The
chemical structures and physical data of all the synthesized
compounds are tabulated in Table 1.
2.2. In Vitro Antimicrobial Activity. The antibacterial activity
of compounds 4(a–h) was evaluated and compared with
bacteriomycin and gentamycin as standard drug (Table 2). All
the tested compounds showed antibacterial activity against
four pathogenic bacterial strains. Among the series, 4(a–
h), compound 4c exhibited an elevated antibacterial activ-
ity against tested bacterial strains. Compounds 4f and 4g
showed good antibacterial activity against all the tested
organisms. Compounds 4h, 4b, 4a, 4d, and 4e showed
moderate inhibitory activity.
The in vitro antifungal activity of the synthesized com-
pounds 4(a–h)was studied against Fusarium oxysporum.The
results were compared with the standard drug nystatin as in
Table 2. Compounds 4c, 4f, and 4g showed good antifungal
activity, when compared with other compounds in the series
against F. oxysporum. Compounds 4h, 4b, 4a, 4d, and 4ewere
found to be moderately active against tested fungal strain.
In the present study, different electron withdrawing and
electron donating groups attached to oxadaizole ring as
substituents were linke to benzene ring. The close survey of
antimicrobial efficacy indicated that the inhibition values of
all the compounds exhibited a varied range of antibacterial
and antifungal activities against all the tested microbial
strains. The electron donating methoxy group in 4c showed
good antimicrobial activity against tested microbial strains.
The methoxy group and electron withdrawing fluorine atom
in 4f and 4g produce enhanced antimicrobial activity. Com-
pounds 4a, 4b, 4d, 4e and 4h exhibited moderate activity
when compared 4c, 4f and 4g. The above studies reveal
that the nature of the linkage (substituent on aromatic ring)
influences the antimicrobial activity. Among the compounds,
4(a–h) showed antimicrobial activity in the order of 4c > 4f
> 4g > 4h > 4b > 4a > 4d > 4e against tested bacterial and
fungal strains.
3. Conclusion
In conclusion, series of new 1,3,4-oxadiazoles, 4(a–h), were
synthesized in good yield and were characterized by different
spectral studies and their antimicrobial activity has been
evaluated. Compounds 4c, 4f, and 4g produced significant
changes in activity against tested microbial strain. Therefore,
this work presents a potent, wide-spectrum antimicrobial
activity of the compounds. The nature of functional linkage
and substituents (electron withdrawing and electron donat-
ing groups) on benzene ring is crucial for antimicrobial
activities.
4. Experimental
4.1. Chemistry. Melting range was determined by Veego
Melting Point VMP-III apparatus. Elemental analyses were
recorded on VarioMICRO superuser V1.3.2 Elementar. The
FT-IR spectra were recorded using KBr discs on FT-IR
Jasco 4100 infrared spectrophotometer. 1H NMR spectra
were recorded on Bruker DRX-500 spectrometer at 400MHz
using CDCl
3
as solvent and TMS as an internal standard.
Mass spectral data were obtained by LC/MSD Trap XCT. All
solvents and reagents were purchased from Sigma-Aldrich
Chemicals Pvt. Ltd.
4.1.1. Synthesis of Ethyl 5-Chloro-2-methoxybenzoate (2). 5-
Chloro-2-methoxybenzoic acid (1) was converted into ethyl
5-chloro-2-methoxybenzoate (2) by the esterification reac-
tion as per the reported procedure[16, 17]. The mixture of
5-chloro-2-methoxybenzoic acid (1, 0.01mmol) was taken
in ethanol (10mL), and thionyl chloride (0.015mmol) was
added slowly and cooled to 5–10∘C. Then the reaction
mass was heated to reflux for 2 hr. The reaction mass was
concentrated through rotavapor under reduced pressure.The
residue was dissolved in dichloromethane and washed with
water. The organic layer was concentrated under reduced
pressure to get the product. Yield: 76%; mp 97–99∘C.
4.1.2. Synthesis of 5-Chloro-2-methoxybenzohydrazide (3).
Compound 2 was converted into 5-chloro-2-methoxy-
benzohydrazide (3), by reacting with hydrazine hydrate in
ethanol medium as per the reported procedure [18, 19]. To a
mixture of ethyl 5-chloro-2-methoxybenzoate (2, 0.01mmol)
and ethanol (10mL) at 0–5∘C, hydrazine hydrate (0.02mmol)
was added. The reaction mass was heated to reflux for 6 hr.
The reaction completionwasmonitored byTLC.The reaction
mixture was concentrated to half volume. The solid obtained
was filtered and washed with ethanol. The obtained solid was
dried to get the pure product. Yield: 74%; mp 144–146∘C.
4.1.3. General Procedure for the Synthesis of 1,3,4-Oxadiazole
Derivatives 4(a–h). An equimolar mixture of acid hydrazide
(3, 0.2mmol) with different aromatic carboxylic acids
(0.0011mmol) was refluxed with phosphorous oxychloride
(5 volume with respect to the weight of compound 3). The
mixture was refluxed at 100∘C for 4 hr. The completion of
the reaction was confirmed by the thin layer chromatography
(TLC). After completion, the reaction mass was cooled to
room temperature and quenched with ice cold water and
stirred for 1 hr. The solid obtained was filtered and washed
with water. Then recrystallised with ethanol and dried to get
the pure product.
Synthesis of 2-(5-Chloro-2-methoxyphenyl)-5-(4-fluorophe-
nyl)-1,3,4-oxadiazole (4a). White solid. FT-IR (KBr, cm−1):
3070 (Ar C–H), 1615 (C=N), 1589 (C=C), 1076 (C–O stretch
of oxadiazole ring). 1H-NMR (400MHz, CDCl
3
): 𝛿 8.09 (d,
2H), 7.98 (s, 1H), 7.47 (d, 2H), 7.01 (d, 2H), 4.01 (s, 3H). MS









(%): C, 59.22 (59.13); H, 3.40 (3.31); N,
9.02 (9.19).
Synthesis of 2-(5-Chloro-2-methoxyphenyl)-5-(4-nitrophenyl)-
1,3,4-oxadiazole (4b). Yellow solid. FT-IR (KBr, cm−1): 3060
(Ar C–H), 1655 (C=N), 1576 (C=C), 1054 (C–O stretch of
oxadiazole ring). 1H-NMR (400MHz, CDCl
3
): 𝛿 8.43 (d,
2H), 8.36 (d, 2H), 8.04 (s, 1H), 7.54–7.05 (d, 2H), 4.02 (s,
International Journal of Medicinal Chemistry 3
Table 1: Chemical structure and physical data of 1,3,4-oxadiazoles 4(a–h).
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Table 1: Continued.











Table 2: In vitro antimicrobial activity of 1,3,4-oxadiazoles 4(a–h).
Compound Zone of inhibition in diameter (mm) Percentage of inhibition
B. subtilis S. aureus X. campestris E. coli F. oxysporum
4a 15 17 18 15 64.5
4b 16 17 19 17 68.4
4c 31 26 30 30 78.1
4d 15 16 17 17 63.0
4e 14 15 16 16 60.2
4f 24 22 23 22 77.3
4g 21 20 21 20 75.7
4h 20 19 20 18 71.4
Bacteriomycin — — 34 — —
Gentamycin 35 30 — 35 —
Nystatin — — — — 100









(%): C, 54.22 (54.31); H, 3.02
(3.04); N, 12.70 (12.67).
Synthesis of 2-(5-Chloro-2-methoxyphenyl)-5-(4-methoxyphe-
nyl)-1,3,4-oxadiazole (4c). White solid. FT-IR (KBr, cm−1):
3070 (Ar C–H), 1675 (C=N), 1576 (C=C), 1054 (C–O stretch
of oxadiazole ring). 1H-NMR (400MHz, CDCl
3
): 𝛿 8.09 (d,
2H), 7.99 (s, 1H), 7.47 (d, 2H), 7.01–7.04 (d, 2H), 3.99 (s, 3H),









(%): C, 60.50 (60.67); H, 4.20
(4.14); N, 8.66 (8.84).
Synthesis of 2-(5-Chloro-2-methoxyphenyl)-5-(4-chlorophen-
yl)-1,3,4-oxadiazole (4d). White solid. FT-IR (KBr, cm−1):
3070 (Ar C–H), 1655 (C=N), 1580 (C=C), 1070 (C–O stretch
of oxadiazole ring). 1H-NMR (400MHz, CDCl
3
): 𝛿 8.19 (d,
2H), 7.85 (s, 1H), 7.58 (d, 2H), 7.25–7.22 (d, 2H), 4.0 (s, 3H).MS











(%): C, 56.15 (56.10); H, 3.05 (3.14); N,
8.80 (8.72).
Synthesis of 2-(5-Chloro-2-methoxyphenyl)-5-(4-bromophen-
yl)-1,3,4-oxadiazole (4e). White solid. FT-IR (KBr, cm−1):
3050 (Ar C–H), 1650 (C=N), 1570 (C=C), 1040 (C–O stretch
of oxadiazole ring). 1H-NMR (400MHz, CDCl
3
): 𝛿 8.01 (d,
2H), 7.88 (s, 1H), 7.56 (d, 2H), 7.29–7.27 (d, 2H), 3.95 (s,









(%): C, 48.20 (49.28); H,
2.66 (2.76); N, 7.60 (7.66).
Synthesis of 2-(5-Chloro-2-methoxyphenyl)-5-(2-fluoro-3-me-
thoxyphenyl)-1,3,4-oxadiazole (4f ). Off-white solid. FT-IR
(KBr, cm−1): 3070 (Ar C–H), 1670 (C=N), 1570 (C=C),
1060 (C–O stretch of oxadiazole ring). 1H-NMR (400MHz,
CDCl
3
): 𝛿 7.89 (s, 1H), 7.80 (s, 1H), 7.43 (d, 2H), 7.29 (d,
1H), 7.17 (m, 1H), 3.90 (s, 3H), 3.88 (s, 3H). MS (ESI)









(%): C, 57.20 (57.41); H, 3.40 (3.61); N, 8.40
(8.37).
Synthesis of 2-(5-Chloro-2-methoxyphenyl)-5-(2-fluoro-5-me-
thoxyphenyl)-1,3,4-oxadiazole (4g). Off white solid. FT-IR
(KBr, cm−1): 3060 (Ar C–H), 1665 (C=N), 1550 (C=C),
1050 (C–O stretch of oxadiazole ring). 1H-NMR (400MHz,
CDCl
3
): 𝛿 7.94 (s, 1H), 7.80 (d, 2H), 7.43 (d, 2H), 7.07 (s, 1H),
4.0 (s, 3H), 3.95 (s, 3H). MS (ESI) 𝑚/𝑧: 334 (M+). Elemental









(57.41); H, 3.52 (3.61); N, 8.40 (8.37).
Synthesis of 2-(5-Chloro-2-methoxyphenyl)-5-(2,6-difluoro-
phenyl)-1,3,4-oxadiazole (4h). White solid. FT-IR (KBr,
cm−1): 3050 (Ar C–H), 1675 (C=N), 1585 (C=C), 1070 (C–
O stretch of oxadiazole ring). 1H-NMR (400MHz, CDCl
3
):
𝛿 8.05 (s, 1H), 7.80 (d, 2H), 7.43 (d, 2H), 7.20 (m, 1H), 3.9
(s, 3H). MS (ESI) 𝑚/𝑧: 322 (M+). Elemental analysis found




































(%): C, 55.70 (55.83); H, 2.72
(2.81); N, 8.50 (8.68).
4.2. Antibacterial Activity. Antibacterial activity of the syn-
thesized compounds was determined against Gram-positive
bacteria (Bacillus subtilis MTCC 121 and Staphylococcus
aureus MTCC 7443) and Gram-negative bacteria (Xan-
thomonas campestrisMTCC 7908 and Escherichia coliMTCC
7410) in DMF by disc diffusion method on nutrient agar
medium [20]. The sterile medium (nutrient agar medium,
15mL) in each Petri plate was uniformly smeared with cul-
tures of Gram-positive and Gram-negative bacteria. Sterile
discs of 10mm diameter (HiMedia) were placed in the Petri
plates, to which 50𝜇L (1mg/mL: i.e., 50𝜇g/disc) of the
different synthesized compounds was added. The treatments
also included 50 𝜇L of DMF as negative, bacteriomycin and
gentamycin as positive control for comparison. For each
treatment, three replicates were maintained. The plates were
incubated at 37 ± 2∘C for 24 h and the zone of inhibition was
determined.
4.3. Antifungal Activity. The synthesized compounds were
screened for their antifungal activity against Fusarium oxys-
porumMTCC 2480 inDMF by poisoned food technique [21].
Potato dextrose agar (PDA)mediumwas prepared and about
15mL of PDA was poured into each Petri plate and allowed
to solidify. Five mm disc of seven-day old culture of the test
fungiwas placed at the center of the Petri plates and incubated
at 26∘C for 7 days. After incubation, the percentage inhibition
was measured and three replicates were maintained for each
treatment. Nystatin was used as standard. All the synthesized
compounds were tested (at the dosage of 500𝜇L of the novel
compounds/Petri plate, where concentration was 0.1mg/mL)
by poisoned food technique.
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